210. Effect of Certolizumab Pegol Over 48 Weeks on Signs and Symptoms in Patients with Psoriatic Arthritis with and Without Prior Tumor Necrosis Factor Inhibitor Exposure

Mease, Philip J.; Fleischmann, Roy; Wollenhaupt, Jürgen; Deodhar, Atul; Gladman, Dafna; Stach, Christian; Hoepken, Bengt; Peterson, Luke; van der Heijde, Desirée

期刊名称Rheumatology
作者Mease, Philip J.; Fleischmann, Roy; Wollenhaupt, Jürgen; Deodhar, Atul; Gladman, Dafna; Stach, Christian; Hoepken, Bengt; Peterson, Luke; van der Heijde, Desirée
卷第53卷
印刷ISSN1462-0324
电子ISSN1462-0332
文件大小74.66KB
发表时间2014-04-01
DOI10.1093/rheumatology/keu115.004

发现好书期刊，享受阅读乐趣

210. Effect of Certolizumab Pegol Over 48 Weeks on Signs and Symptoms in Patients with Psoriatic Arthritis with and Without Prior Tumor Necrosis Factor Inhibitor Exposure